Kazakhstan Approves New Russian Diabetes Drug
Russia’s Promomed biopharmaceutical company has received approval from the Kazakh Ministry of Health to supply Tirzetta, a drug used in the treatment of type II diabetes mellitus and obesity. It is also commonly marketed as a ‘beauty’ weight loss medication. According to the WHO, 56% of Kazakhstan’s adult population are overweight.
Русский







